Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review
Viruses · 2024
DOI: 10.3390/v16020220 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Viruses, 2024. Verfasst von Kazuma Yagi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Gastrointestinal Microbiome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health.
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) infection is a major cause of lower respiratory tract infection, especially in infants, and increases the risk of recurrent wheezing and asthma. Recently, researchers have proposed a possible association between respiratory diseases and microbiome alterations. However, this connection has not been fully established. Herein, we conducted a systematic literature review to evaluate the reported evidence of microbiome alterations in patients with RSV infection.
Methods
The systematic literature review on the association between RSV and microbiome in humans was conducted by searching PubMed, EMBASE, Scopus, and CINAHL from 2012 until February 2022. The results were analyzed qualitatively, focusing on the relationship between microbiome and RSV infection with available key microbiome-related parameters.
Results
In the 405 articles identified by searching databases, 12 (Respiratory tract: 9, Gut: 2, Both: 1) articles in line with the research aims were eligible for this qualitative review. The types of samples for the respiratory tract microbiome and the sequencing methods utilized varied from study to study. This review revealed that the overall microbial composition in both the respiratory tract and gut in RSV-infected patients was different from that in healthy controls. Our generated results demonstrated an increase in the abundance of Haemophilus and Streptococcus, which could contribute to the distinctive separation based on the beta diversity in the respiratory tract.
Conclusions
The respiratory tract and gut microbiome changed in patients with RSV infection. Further research with a well-organized longitudinal design is warranted to clarify the impact of microbiome alterations on disease pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Department of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Department of Pharmacy, Mie University Hospital, Tsu 514-8507, Japan.
- Department of Clinical Pharmaceutics, Division of Clinical Medical Science, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
ORCID-Profile: Kazuma Yagi, Nicholas W Lukacs, Hideo Kato
Förderung
- National Institute of Health
Zitieren
APA
Yagi, K., Lukacs, N. W., Huffnagle, G. B., Kato, H., & Asai, N. (2024). Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses. https://doi.org/10.3390/v16020220
Vancouver
Yagi K, Lukacs NW, Huffnagle GB, Kato H, Asai N. Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review. Viruses. 2024. doi:10.3390/v16020220
BibTeX
@article{Yagi2024,
author = {Yagi, Kazuma and Lukacs, Nicholas W and Huffnagle, Gary B and Kato, Hideo and Asai, Nobuhiro},
title = {Respiratory and Gut Microbiome Modification during Respiratory Syncytial Virus Infection: A Systematic Review},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16020220}
}
EUVIMED